Wang, Z., Kang, W., Li, O., Qi, F., Wang, J., You, Y., . . . Liu, H. (2021). Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing. Acta pharmaceutica Sinica. B, 11(3), 694-707. https://doi.org/10.1016/j.apsb.2020.11.005
Chicago Style (17th ed.) CitationWang, Zhiru, et al. "Abrogation of USP7 Is an Alternative Strategy to Downregulate PD-L1 and Sensitize Gastric Cancer Cells to T Cells Killing." Acta Pharmaceutica Sinica. B 11, no. 3 (2021): 694-707. https://doi.org/10.1016/j.apsb.2020.11.005.
MLA (9th ed.) CitationWang, Zhiru, et al. "Abrogation of USP7 Is an Alternative Strategy to Downregulate PD-L1 and Sensitize Gastric Cancer Cells to T Cells Killing." Acta Pharmaceutica Sinica. B, vol. 11, no. 3, 2021, pp. 694-707, https://doi.org/10.1016/j.apsb.2020.11.005.